ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,801 | 37.70798 | 1 | male | 0 | 17 | 95 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 41 | 28,257.281 | 19,791.9219 | null | 13 | black | 27.597656 | 44 | 0.736938 | 0.654907 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 123 | 2.399902 | 120 | 22 | 39.19531 | 485.6875 | 1.399902 | 3.799805 | 0.899902 | 145 | 7.489258 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,802 | 51.80798 | 1 | male | 0 | 36 | 224 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 85,036.875 | 57,495.9688 | null | 29.25 | white | 36.695313 | 54 | 0.62793 | 0.524902 | 1 | 0 | 0 | no | null | null | dnr after sadm | 23 | 69 | 18.898438 | 110 | 10 | 36.29688 | 90 | 2.299805 | 7.299805 | 1.299805 | 150 | 7.5 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
3,803 | 34.905 | 1 | female | 0 | 32 | 426 | Lung Cancer | Cancer | 1 | 15 | $11-$25k | 0 | 30,184.844 | 22,470.3438 | null | 10.5 | black | 12.898438 | 10 | 0.830933 | 0.631958 | 1 | 0 | 0 | metastatic | 0.7 | 0.2 | no dnr | 32 | 83 | 1.099854 | 80 | 16 | 36.79688 | null | null | 0.399963 | 1.099854 | 142 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,804 | 67.16797 | 1 | male | 0 | 5 | 239 | Colon Cancer | Cancer | 1 | 19 | $25-$50k | 0 | 2,869.35 | 2,204.5879 | null | 12 | white | 13.199219 | 15 | 0.858887 | 0.685913 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 5 | 105 | 5.399414 | 72 | 20 | 36.59375 | null | null | 0.299988 | 1 | 142 | null | null | null | null | 0 | 0 | null | 0 |
3,805 | 75.53198 | 1 | female | 1 | 26 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 89 | 65,764.688 | 46,593.75 | null | 30 | black | 48.09375 | 75 | 0 | 0 | 5 | 1 | 0 | no | 0.2 | 0.2 | dnr after sadm | 13 | 43 | 9.599609 | 0 | 25 | 35.59375 | 294 | null | 1.299805 | 3.399902 | 149 | 7.359375 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,806 | 59.53699 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 100 | 36,440.969 | 26,306.7969 | null | 48 | white | 76 | 97 | 0 | 0 | 3 | 1 | 0 | no | null | null | dnr after sadm | 3 | 0 | 26.296875 | 0 | 25 | 36.79688 | 151 | 3.199707 | 0.399963 | 10.099609 | 131 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 2.06543 |
3,807 | 52.49799 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 100 | 64,625.125 | 37,736.7812 | null | 60 | white | 73 | 101 | 0 | 0 | 18 | 1 | 0 | no | 0 | 0 | no dnr | 3 | 32 | 60.09375 | 0 | 12 | 38.09375 | 58 | null | 17.199219 | 4.699219 | 128 | 7.179688 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,808 | 33.49799 | 0 | male | 0 | 17 | 1,650 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 0 | 38,352.75 | 26,380.8906 | null | 28 | black | 41.5 | 38 | 0.61792 | 0.512939 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 17 | 46 | 10.199219 | 114 | 34 | 34.89844 | 138.3125 | 3.299805 | 0.799927 | 0.5 | 138 | 7.339844 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
3,809 | 63.31299 | 1 | male | 0 | 7 | 1,023 | Colon Cancer | Cancer | 1 | null | null | 0 | 6,546.547 | 4,539.9961 | null | 10.5 | white | 17 | 13 | 0.819946 | 0.610962 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 7 | 125 | 7.699219 | 100 | 20 | 36.19531 | null | null | 0.299988 | 0.799927 | 139 | null | null | null | null | null | null | null | 2.276367 |
3,810 | 71.09698 | 1 | male | 0 | 8 | 67 | Colon Cancer | Cancer | 1 | 5 | $11-$25k | 0 | 6,796.148 | 4,837.2031 | null | 15.5 | white | 37.09375 | 29 | 0.33197 | 0.064987 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 8 | 90 | 13.298828 | 100 | 20 | 38 | null | 1.799805 | 2.399902 | 1 | 135 | null | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
3,811 | 33.336 | 0 | female | 0 | 16 | 1,648 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | $11-$25k | 0 | 38,332.438 | 27,009.375 | null | 21 | white | 23.796875 | 48 | 0.883911 | 0.842896 | 2 | 0 | 0 | no | null | null | no dnr | 16 | 145 | 21.199219 | 124 | 25 | 35.89844 | 300 | 1 | 0.199982 | 0.899902 | 135 | 7.509766 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,812 | 68.323 | 1 | male | 1 | 9 | 9 | Coma | Coma | 1 | 11 | $25-$50k | 89 | 40,760.781 | 27,743.625 | null | 30.5 | white | 20.199219 | 38 | 0.205994 | 0.144989 | 3 | 0 | 0 | yes | null | null | dnr after sadm | 6 | 115 | 3.899902 | 110 | 40 | 38.29688 | 276.625 | 2.5 | 2 | 1.399902 | 139 | 7.519531 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,813 | 70.06195 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 0 | 60,256.219 | 41,535.4375 | null | 42.5 | black | 22.097656 | 32 | 0.776978 | 0.704956 | 6 | 1 | 0 | no | 0 | 0 | no dnr | 10 | 105 | 7.299805 | 126 | 32 | 36.09375 | 223.3125 | null | 1.099854 | 1.199951 | 142 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.163086 |
3,814 | 30.56499 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 41 | 111,994.75 | 75,745.25 | null | 48 | black | 34.09375 | 53 | 0.554932 | 0.441956 | 9 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 14 | 101 | 17.199219 | 114 | 9 | 35.29688 | 253.3125 | 1.099854 | 5.299805 | 4.199219 | 137 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,815 | 55.047 | 0 | male | 0 | 17 | 1,648 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $25-$50k | 0 | 57,010.281 | 37,786.875 | null | 36 | white | 28.597656 | 41 | 0.773926 | 0.700928 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 17 | 62 | 10.5 | 136 | 22 | 37.89844 | 140.8125 | null | null | 2 | 142 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,816 | 64.51495 | 0 | male | 0 | 43 | 1,647 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 0 | 134,926.125 | 87,521.75 | null | 12.5 | white | 21.898438 | 29 | 0.80896 | 0.745972 | 4 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 43 | 62 | 11.199219 | 108 | 30 | 38.89844 | 196.65625 | null | null | 1 | 137 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,817 | 72.55896 | 1 | male | 1 | 26 | 26 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 0 | 117,551.375 | 78,834 | null | 50.5 | white | 49.09375 | 62 | 0.018997 | 0.004 | 2 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 5 | 43 | 1.399902 | 46 | 30 | 38.5 | 132.625 | 2.799805 | 1.599854 | 3.399902 | 145 | 7.399414 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,818 | 53.771 | 1 | male | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 0 | 144,017.875 | 95,878.5 | null | 43.75 | black | 33.09375 | 47 | 0.650879 | 0.55188 | 4 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 28 | 65 | 21.597656 | 136 | 40 | 39.69531 | 127.5 | 1.099854 | null | 0.5 | 135 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,819 | 36.78 | 0 | male | 0 | 34 | 1,645 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 69,588.438 | 47,347.7812 | null | 20.75 | white | 23.398438 | 42 | 0.879883 | 0.837891 | 2 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 34 | 110 | 27.097656 | 64 | 29 | 36.79688 | 196.65625 | 2.5 | 2.199707 | 1.599854 | 143 | 7.449219 | null | null | null | 6 | 6 | adl>=4 (>=5 if sur) | 6 |
3,820 | 57.37198 | 0 | female | 0 | 5 | 1,644 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,919.348 | 4,499.9922 | null | 27 | black | 25.199219 | 40 | 0.824951 | 0.714966 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 5 | 57 | 11.298828 | 74 | 12 | 36 | null | null | null | 1.799805 | 131 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,821 | 66.06696 | 1 | male | 0 | 11 | 108 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 8,746.344 | 6,254.4844 | null | 8.5 | white | 22.199219 | 23 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 11 | 101 | 12.5 | 120 | 24 | 36.19531 | 314.8125 | null | null | 1.399902 | 138 | 7.379883 | null | null | null | 5 | 6 | adl>=4 (>=5 if sur) | 6 |
3,822 | 44.71198 | 1 | female | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 2 | 10 | under $11k | 0 | 34,335.719 | 23,017.6406 | null | 40.5 | black | 24.699219 | 48 | 0.580933 | 0.471985 | 6 | 1 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 8 | 82 | 30.398438 | 136 | 37 | 38.09375 | 193.3125 | 1.799805 | 0.399963 | 0.899902 | 148 | 7.509766 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
3,823 | 66.53296 | 1 | male | 0 | 53 | 941 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | null | 26 | 84,241.938 | 57,762.9375 | null | 20.75 | black | 17.5 | 11 | 0.806885 | 0.741943 | 3 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 53 | 113 | 7.399414 | 64 | 22 | 35.29688 | 390.4375 | null | null | 1 | 139 | 7.389648 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,824 | 64.47095 | 1 | female | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $11-$25k | 61 | 239,038.625 | 153,327.625 | null | 46.25 | white | 42.5 | 82 | 0.035995 | 0.009998 | 38 | 0 | 0 | no | null | null | dnr after sadm | 19 | 79 | 25.699219 | 150 | 14 | 38.5 | 274.25 | 3.699707 | 46 | 2.299805 | 156 | 7.509766 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,825 | 86.771 | 1 | male | 0 | 12 | 92 | COPD | COPD/CHF/Cirrhosis | 1 | 6 | $25-$50k | 0 | 9,572.992 | 6,706.3945 | null | 12 | white | 16.398438 | 24 | 0.793945 | 0.668945 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 1 | 77 | 5.399414 | 96 | 24 | 36.29688 | 254.15625 | null | 0.699951 | 0.899902 | 144 | 7.319336 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
3,826 | 65.84497 | 1 | male | 0 | 11 | 21 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 36,142.5 | 23,028.0938 | null | 36 | white | 30.796875 | 45 | 0.694946 | 0.529907 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 11 | 56 | 7.5 | 96 | 26 | 34.89844 | 173.3125 | null | null | 0.699951 | 130 | 7.509766 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,827 | 36.46298 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 44 | 43,674.094 | 27,369.0312 | null | 40.5 | black | 36.09375 | 49 | 0.539917 | 0.425964 | 1 | 0 | 0 | no | null | null | dnr after sadm | 7 | 49 | 6.699219 | 130 | 10 | 36.89844 | 380 | null | 3.799805 | 3.299805 | 143 | 7.419922 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,828 | 66.01196 | 1 | female | 0 | 6 | 809 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | under $11k | 0 | 4,544.449 | 3,349.0293 | null | 13 | white | 17.097656 | 29 | 0.885986 | 0.809937 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 6 | 73 | 7.599609 | 80 | 20 | 36 | 232 | null | null | 1.599854 | 142 | 7.40918 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,829 | 57.34399 | 1 | male | 0 | 14 | 120 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 16,616.234 | 11,228.8359 | null | 13 | white | 18.398438 | 26 | 0.894897 | 0.824951 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 14 | 73 | 8 | 114 | 16 | 35.29688 | 361.875 | 4 | 0.5 | 1.299805 | 142 | 7.469727 | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
3,830 | 64.30096 | 1 | male | 0 | 4 | 107 | Colon Cancer | Cancer | 1 | 8 | $25-$50k | 0 | 2,797.75 | 1,885.8486 | null | 14 | white | 26.097656 | 14 | 0.656982 | 0.352966 | 1 | 0 | 0 | metastatic | 0.75 | 0.25 | no dnr | 4 | 103 | 10 | 100 | 20 | 36.59375 | null | 2.899902 | 1.099854 | 0.599976 | 135 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
3,831 | 74.836 | 1 | male | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | null | 9 | 100,695.688 | 62,287.8438 | null | 50.333313 | white | 33.796875 | 69 | 0.472961 | 0.35498 | 3 | 1 | 0 | no | null | null | no dnr | 20 | 114 | 11.599609 | 154 | 51 | 38 | 176.65625 | 3 | 0.099991 | 5.099609 | 148 | 7.429688 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,832 | 44.45697 | 1 | female | 0 | 23 | 1,124 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 64,678.375 | 43,669.75 | null | 35.333313 | white | 27.699219 | 34 | 0.822998 | 0.762939 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 23 | 71 | 13.199219 | 120 | 40 | 39 | 169.375 | null | 0.5 | 1.199951 | 152 | 7.369141 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,833 | 65.17694 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 75,953.688 | 54,295.0625 | null | 45 | white | 39.796875 | 68 | 0.146973 | 0.069992 | 57 | 1 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 2 | 52 | 0.099991 | 146 | 23 | 39 | 126.65625 | 2.399902 | 1.099854 | 0.799927 | 139 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.153809 |
3,834 | 40.961 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 37 | 26,437.453 | 17,019.7812 | null | 36 | white | 25.296875 | 49 | 0.726929 | 0.642944 | 6 | 0 | 0 | no | 0 | 0 | dnr after sadm | 4 | 60 | 6.5 | 134 | 42 | 38.5 | 200 | null | 0.299988 | 1.799805 | 143 | 7.389648 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,835 | 46.20099 | 1 | male | 0 | 16 | 494 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 0 | 48,938.625 | 31,128.8594 | null | 32 | white | 26.597656 | 23 | 0.831909 | 0.774902 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 16 | 47 | 7.699219 | 114 | 8 | 38.09375 | 205 | 2.699707 | 1.599854 | 0.799927 | 142 | 7.339844 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
3,836 | 46.80099 | 1 | female | 0 | 24 | 81 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 100,731.312 | 67,725 | null | 19.666656 | white | 25.398438 | 39 | 0.583984 | 0.474976 | 45 | 0 | 0 | yes | 0.2 | 0.1 | no dnr | 24 | 70 | 0.299988 | 80 | 24 | 36.09375 | 215 | 2.299805 | 1.399902 | 0.799927 | 138 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,837 | 71.78894 | 1 | male | 0 | 13 | 540 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 14,408.992 | 9,772.8594 | null | 13.5 | white | 18.199219 | 29 | 0.861938 | 0.770996 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 13 | 82 | 5.799805 | 76 | 20 | 35.79688 | 304.75 | null | 0.399963 | 1.799805 | 144 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,838 | 33.98798 | 0 | male | 0 | 11 | 1,627 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 32,652.094 | 21,513.1094 | null | 12 | white | 13.599609 | 12 | 0.941895 | 0.919922 | 4 | 0 | 0 | no | 0.98 | 0.97 | no dnr | 11 | 107 | 8.798828 | 78 | 24 | 36.69531 | 348.9375 | null | null | 1.199951 | 137 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,839 | 34.44498 | 0 | male | 0 | 55 | 1,627 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 90,605.125 | 61,912.2812 | null | 25 | black | 33 | 80 | 0.781982 | 0.711914 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 55 | 59 | 28.5 | 70 | 19 | 35.29688 | 323.75 | 1.799805 | 8.599609 | 2.399902 | 153 | 7.469727 | null | null | null | null | 0 | null | 0 |
3,840 | 62.37598 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 26,869.891 | 15,855.4297 | null | 49.5 | black | 46.296875 | 55 | 0.286987 | 0.176971 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 7 | 42 | 13.5 | 116 | 14 | 35.5 | 173.46875 | 2.299805 | null | 2.599609 | 129 | 7.329102 | null | null | null | null | null | <2 mo. follow-up | 2.303711 |
3,841 | 72.73895 | 1 | male | 0 | 14 | 103 | COPD | COPD/CHF/Cirrhosis | 3 | 6 | $11-$25k | 0 | 237,319.75 | 164,784.5 | null | 9.333328 | white | 22.097656 | 32 | 0.712891 | 0.554932 | 105 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 57 | 7.399414 | 116 | 24 | 36.19531 | 259.25 | null | null | 0.899902 | 135 | 7.349609 | null | null | null | 0 | 0 | SIP>=30 | 0 |
3,842 | 62.60397 | 1 | male | 0 | 8 | 785 | Colon Cancer | Cancer | 1 | 16 | $11-$25k | 0 | 6,939.148 | 4,463.418 | null | 8.5 | white | 11.699219 | 11 | 0.879883 | 0.727905 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 8 | 113 | 4.299805 | 66 | 16 | 37.69531 | null | 3.599609 | 0.599976 | 1.099854 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,843 | 73.05695 | 1 | male | 0 | 13 | 127 | MOSF w/Malig | ARF/MOSF | 1 | 8 | $11-$25k | 0 | 26,677.734 | 17,147.4219 | null | 24.5 | white | 28.898438 | 42 | 0.490967 | 0.372986 | 1 | 0 | 0 | metastatic | null | null | no dnr | 13 | 69 | 20.296875 | 134 | 36 | 38 | 128.5625 | null | null | 1.299805 | 142 | 7.5 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
3,844 | 33.30899 | 0 | male | 0 | 3 | 1,625 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 1,949.499 | 1,513.6387 | null | 6 | white | 25.199219 | 34 | 0.893921 | 0.821899 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 3 | 93 | 14.298828 | 102 | 18 | 36.5 | 319 | null | null | 5.5 | 135 | 7.359375 | null | null | null | null | null | no(M2 and SIP pres) | 2.129395 |
3,845 | 39.392 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 37 | 25,431.641 | 16,257.5078 | null | 24.5 | black | 23.097656 | 45 | 0.813965 | 0.751953 | 1 | 0 | 0 | no | 0.25 | 0.2 | dnr after sadm | 12 | 59 | 35.296875 | 100 | 32 | 36.39844 | 428 | 2 | 2 | 1.099854 | 133 | 7.439453 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,846 | 50.297 | 1 | male | 0 | 24 | 55 | CHF | COPD/CHF/Cirrhosis | 3 | 17 | $25-$50k | 0 | 37,236.906 | 23,530.2969 | null | 20.333328 | white | 15.898438 | 25 | 0.925903 | 0.873901 | 1 | 1 | 0 | no | 0.75 | 0.6 | dnr after sadm | 16 | 79 | 6 | 76 | 28 | 36.29688 | 342.8125 | null | 1.199951 | 1.099854 | 138 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,847 | 62.64798 | 1 | female | 1 | 19 | 19 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 37 | 114,017.812 | 77,522.1875 | null | 42.666657 | white | 38.695313 | 39 | 0.058998 | 0.019997 | 23 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 15 | 113 | 13.798828 | 136 | 33 | 36.19531 | 55 | null | null | 0.699951 | 130 | 7.419922 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,848 | 46.431 | 0 | male | 0 | 6 | 1,625 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 18 | >$50k | 0 | 13,625.547 | 10,169 | null | 11 | white | 22 | 32 | 0.832886 | 0.726929 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 109 | 7.599609 | 92 | 20 | 38.19531 | 154 | 2.199707 | 5.199219 | 0.799927 | 141 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,849 | 44.48199 | 1 | male | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 15 | $25-$50k | 26 | 14,491.094 | 9,780.6641 | null | 20 | white | 49.398438 | 65 | 0.025997 | 0.006 | 1 | 1 | 0 | yes | 0 | 0 | dnr after sadm | 3 | 46 | 1.099854 | 130 | 12 | 36.29688 | 165.28125 | 1.699951 | null | 1.5 | 125 | 7.369141 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
3,850 | 38.22598 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 113,644.312 | 77,640.1875 | null | 34.666657 | black | 24 | 37 | 0.762939 | 0.68689 | 37 | 0 | 0 | no | 0 | 0 | dnr after sadm | 6 | 53 | 9.5 | 166 | 20 | 38.59375 | 222.84375 | null | 0.799927 | 1.199951 | 147 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.05957 |
3,851 | 43.46899 | 0 | male | 0 | 6 | 1,623 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 9,109.25 | 5,954.8867 | null | 6 | white | 17.5 | 20 | 0.92688 | 0.875977 | 1 | 1 | 0 | no | 0.9 | 0.5 | no dnr | 6 | 79 | 7 | 60 | 16 | 36 | null | null | 1.599854 | 1.199951 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,852 | 53.448 | 0 | male | 0 | 5 | 1,623 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | $25-$50k | 0 | 8,706.695 | 5,779.0469 | null | 12 | white | 18 | 17 | 0.906982 | 0.842896 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 81 | 10.5 | 76 | 20 | 36.19531 | null | null | 0.599976 | 1.799805 | 140 | null | null | null | null | null | null | null | 1.733887 |
3,853 | 53.86697 | 1 | male | 0 | 6 | 71 | Lung Cancer | Cancer | 1 | 3 | under $11k | 0 | 4,178.297 | 2,940.7246 | null | 6 | black | 19.097656 | 24 | 0.691895 | 0.401978 | 1 | 0 | 0 | metastatic | 0.75 | 0.4 | no dnr | 6 | 70 | 42.398438 | 106 | 20 | 36.29688 | null | 3.799805 | 0.699951 | 1.399902 | 141 | null | null | null | null | null | 7 | SIP>=30 | 7 |
3,854 | 63.51797 | 0 | female | 0 | 7 | 1,621 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | $25-$50k | 0 | 12,290.547 | 9,199.0156 | null | 20.5 | black | 26.199219 | 46 | 0.787964 | 0.660889 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 122 | 11.298828 | 70 | 15 | 36.59375 | 156.65625 | null | null | 3.099609 | 136 | 7.369141 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,855 | 43.50699 | 1 | male | 0 | 23 | 530 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | $11-$25k | 0 | 35,417.5 | 23,980.9844 | null | 18 | white | 24 | 26 | 0.908936 | 0.846924 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 23 | 71 | 13.298828 | 66 | 14 | 35.39844 | 160 | null | null | 0.899902 | 134 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,856 | 49.79898 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 9 | 44,865.125 | 29,697.0312 | null | 33 | hispanic | 34.898438 | 56 | 0.279968 | 0.17099 | 18 | 0 | 0 | yes | 0.5 | 0.2 | dnr after sadm | 6 | 66 | 0.099991 | 120 | 12 | 36 | 177.5 | 1.399902 | 1.199951 | 0.799927 | 136 | 7.319336 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,857 | 64.12897 | 1 | female | 0 | 6 | 344 | Colon Cancer | Cancer | 1 | 13 | null | 0 | 4,552 | 3,259.5019 | null | 9 | white | 14.298828 | 11 | 0.850952 | 0.670898 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 6 | 80 | 8.599609 | 60 | 16 | 37.5 | null | null | null | 1.099854 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,858 | 40.88397 | 0 | female | 0 | 35 | 1,619 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 0 | 164,417.875 | 116,632.562 | null | 32.25 | white | 33.296875 | 71 | 0.678955 | 0.508911 | 1 | 0 | 0 | no | null | null | no dnr | 35 | 59 | 12 | 118 | 41 | 38.69531 | 165 | 0.399963 | 14.398438 | 1 | 147 | 7.519531 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,859 | 65.92999 | 1 | female | 0 | 14 | 867 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 31,304.594 | 21,216.1562 | null | 19.666656 | white | 17.796875 | 19 | 0.881958 | 0.803955 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 14 | 105 | 9.099609 | 60 | 8 | 37.59375 | 216.65625 | null | 2.699707 | 0.699951 | 141 | 7.429688 | null | null | null | null | 0 | null | 0 |
3,860 | 63.88498 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 70,330.438 | 44,525.8125 | null | 56 | white | 60.898438 | 101 | 0 | 0 | 19 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 3 | 42 | 0.299988 | 210 | 40 | 40.09375 | 57 | 3.199707 | 3.599609 | 1.699951 | 154 | 7.389648 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,861 | 70.51599 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 72,465.938 | 44,700.5 | null | 55 | white | 36.398438 | 54 | 0.158997 | 0.077988 | 24 | 0 | 0 | metastatic | null | null | no dnr | 8 | 61 | 18.398438 | 166 | 16 | 39 | 70 | 2.899902 | 5.699219 | 1.399902 | 136 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 2.52002 |
3,862 | 59.69299 | 1 | male | 0 | 8 | 55 | CHF | COPD/CHF/Cirrhosis | 4 | 7 | null | 0 | 6,527.398 | 4,549.4727 | null | 13 | white | 23.199219 | 24 | 0.841919 | 0.740967 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 65 | 12.599609 | 94 | 20 | 35.09375 | 348 | null | 1.699951 | 1.699951 | 141 | 7.449219 | null | null | null | 3 | 3 | <2 mo. follow-up | 3 |
3,863 | 51.01398 | 1 | female | 0 | 18 | 1,124 | MOSF w/Malig | ARF/MOSF | 3 | 14 | null | 0 | 26,606.234 | 19,481.5 | null | 18.666656 | white | 25.699219 | 27 | 0.661987 | 0.563965 | 2 | 0 | 0 | yes | null | null | no dnr | 18 | 64 | 9.898438 | 110 | 16 | 35.89844 | 236 | null | null | 1 | 126 | 7.55957 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
3,864 | 39.98898 | 0 | male | 0 | 47 | 1,616 | Coma | Coma | 0 | 11 | $11-$25k | 44 | 96,140.5 | 65,851.3125 | null | 27 | black | 22.199219 | 28 | 0.740967 | 0.692993 | 1 | 0 | 0 | no | null | null | no dnr | 47 | 150 | 21.5 | 54 | 16 | 36.5 | 314.25 | null | 0.799927 | 2 | 142 | 7.549805 | null | null | null | null | 0 | null | 0 |
3,865 | 77.36896 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 3 | 16 | $11-$25k | 0 | 82,882 | 50,108.625 | null | 50 | white | 35.59375 | 64 | 0.181 | 0.093994 | 13 | 1 | 0 | metastatic | 0 | 0 | no dnr | 6 | 56 | 27.796875 | 144 | 15 | 36.39844 | 95 | 3 | 0.599976 | 1.899902 | 137 | 7.329102 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,866 | 49.28699 | 1 | female | 0 | 3 | 93 | Lung Cancer | Cancer | 1 | 18 | >$50k | 0 | 6,130.148 | 3,425.2812 | null | 9 | white | 28.097656 | 14 | 0.480957 | 0.162994 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 3 | 93 | 50 | 92 | 18 | 36.89844 | null | 2.599609 | 0.299988 | 0.899902 | 137 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
3,867 | 42.38199 | 1 | male | 0 | 13 | 161 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 61 | 17,956.734 | 11,401.1875 | null | 17 | white | 23.796875 | 9 | 0.720947 | 0.635986 | 1 | 0 | 0 | no | null | null | no dnr | 13 | 100 | 10.398438 | 104 | 22 | 39.09375 | 165.28125 | null | null | 0.599976 | 145 | 7.40918 | null | null | null | null | 7 | null | 7 |
3,868 | 72.82996 | 1 | male | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 26 | $25-$50k | 26 | 64,584.969 | 42,675.625 | null | 16.5 | white | 19.699219 | 24 | 0.653931 | 0.554932 | 9 | 0 | 0 | yes | 0.7 | 0.5 | no dnr | 28 | 123 | 25.597656 | 100 | 26 | 38.09375 | 220 | null | null | 0.799927 | 136 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,869 | 38.63397 | 1 | male | 0 | 40 | 280 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 0 | 64,797.125 | 45,844.5625 | null | 13.75 | white | 26.796875 | 52 | 0.851929 | 0.799927 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 40 | 148 | 10.298828 | 64 | 35 | 36 | 280.9375 | 2.699707 | 0.199982 | 8.199219 | 129 | 7.379883 | null | null | null | 5 | 6 | SIP>=30 | 6 |
3,870 | 57.33099 | 1 | female | 0 | 9 | 24 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 0 | 7,634.297 | 5,276.5508 | null | 14 | white | 20.199219 | 25 | 0.80188 | 0.680908 | 1 | 0 | 0 | no | null | 0.6 | no dnr | 9 | 77 | 5.5 | 80 | 22 | 36.5 | null | 3.299805 | 4 | 1.199951 | 128 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,871 | 71.51495 | 1 | male | 1 | 7 | 7 | Coma | Coma | 1 | null | null | 61 | 79,534.062 | 50,686.5625 | null | 28.5 | black | 24.296875 | 42 | 0.237976 | 0.172974 | 8 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 60 | 12.699219 | 114 | 12 | 39.5 | 208.5625 | null | null | 9.798828 | 140 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,872 | 70.30798 | 1 | male | 1 | 16 | 16 | MOSF w/Malig | ARF/MOSF | 1 | 17 | >$50k | 9 | 65,747 | 42,281.875 | null | 39.666657 | white | 29.597656 | 54 | 0.488953 | 0.370972 | 2 | 0 | 0 | yes | null | null | no dnr | 16 | 56 | 9.699219 | 130 | 29 | 37.89844 | 226.65625 | 2.599609 | 1.299805 | 3.699707 | 137 | 7.489258 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,873 | 51.258 | 1 | female | 0 | 6 | 659 | Colon Cancer | Cancer | 1 | 11 | >$50k | 0 | 6,629.898 | 3,985.4883 | null | 18 | white | 15.5 | 15 | 0.85791 | 0.68396 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 150 | 6.399414 | 68 | 20 | 36.5 | null | null | 0.599976 | 0.699951 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,874 | 40.75 | 0 | male | 0 | 29 | 1,610 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 26 | 56,770.312 | 38,207.1875 | null | 28.25 | white | 22.5 | 35 | 0.841919 | 0.787964 | 1 | 0 | 0 | no | 0.95 | 0.94 | no dnr | 29 | 77 | 13.798828 | 124 | 38 | 38.19531 | 233.3125 | 2.099609 | 0.5 | 0.599976 | 137 | 7.479492 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,875 | 71.03595 | 1 | female | 1 | 50 | 50 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 101,556.688 | 70,590.1875 | null | 7.75 | white | 17.898438 | 21 | 0.812988 | 0.697998 | 14 | 0 | 0 | no | 0.75 | 0.6 | dnr after sadm | 46 | 73 | 9.099609 | 70 | 28 | 36.19531 | 736.625 | null | null | 0.699951 | 137 | 7.40918 | null | null | null | 2 | 0 | <2 mo. follow-up | 0 |
3,876 | 68.01898 | 1 | male | 0 | 5 | 165 | Colon Cancer | Cancer | 1 | 7 | null | 0 | 3,755.648 | 2,598.2031 | null | 17 | white | 16.597656 | 21 | 0.816895 | 0.605957 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 5 | 107 | 7 | 76 | 24 | 36.19531 | null | null | 0.399963 | 1.699951 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,877 | 67.11298 | 1 | male | 0 | 33 | 1,564 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 0 | 73,551.25 | 47,569.375 | null | 30.25 | black | 28 | 39 | 0.733887 | 0.650879 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 33 | 67 | 19.699219 | 114 | 8 | 39.09375 | 195 | null | 1.5 | 2.099609 | 132 | 7.509766 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
3,878 | 53.04898 | 1 | female | 1 | 6 | 6 | Coma | Coma | 0 | null | null | 61 | 33,600.531 | 21,992.5469 | null | 43 | other | 22 | 38 | 0.412964 | 0.338989 | 7 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 5 | 62 | 2.299805 | 136 | 27 | 37.89844 | 273.3125 | null | null | 1.399902 | 150 | 7.5 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,879 | 61.06198 | 0 | male | 0 | 14 | 1,600 | Coma | Coma | 1 | 12 | >$50k | 26 | 25,385.047 | 16,424.75 | null | 19 | white | 16.5 | 7 | 0.766968 | 0.7229 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 14 | 105 | 18.898438 | 74 | 8 | 36.5 | 310 | null | null | 1.099854 | 135 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,880 | 24.01399 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 98,734 | 63,452.4688 | null | 38.333313 | white | 32.898438 | 41 | 0.711914 | 0.623901 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 17 | 112 | 16.898438 | 144 | 30 | 40 | 110 | null | 0.899902 | 0.699951 | 147 | 7.489258 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,881 | 54.02899 | 0 | male | 0 | 5 | 1,599 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | $11-$25k | 0 | 9,305.555 | 6,273.5117 | null | 25 | white | 23.898438 | 27 | 0.851929 | 0.756958 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 53 | 6.899414 | 54 | 11 | 36.09375 | 316 | null | null | 1.199951 | 138 | 7.389648 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,882 | 45.81497 | 1 | male | 1 | 3 | 3 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 100 | 20,466.234 | 13,310 | null | 42 | white | 75.796875 | 87 | 0 | 0 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 0 | 7.199219 | 0 | 22 | 36.39844 | 155.6875 | 1.899902 | null | 4.199219 | 152 | 7.25 | null | null | null | null | null | <2 mo. follow-up | 2.129883 |
3,883 | 62.65298 | 1 | female | 0 | 10 | 604 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 9,345.742 | 6,544.2227 | null | 14.5 | white | 18.097656 | 12 | 0.885986 | 0.809937 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 10 | 87 | 10.798828 | 74 | 26 | 36.19531 | 436 | null | null | 1.099854 | 147 | 7.419922 | null | null | null | 2 | 3 | no(M2 and SIP pres) | 3 |
3,884 | 48.95599 | 1 | male | 1 | 69 | 69 | MOSF w/Malig | ARF/MOSF | 1 | 18 | $25-$50k | 0 | 158,581.125 | 105,985.688 | null | 33.75 | white | 26.398438 | 37 | 0.580933 | 0.470947 | 12 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 62 | 111 | 6.699219 | 114 | 11 | 36.29688 | 202.84375 | null | null | 6.899414 | 141 | 7.40918 | null | null | null | null | 0 | null | 0 |
3,885 | 68.60199 | 1 | female | 0 | 26 | 244 | MOSF w/Malig | ARF/MOSF | 1 | 13 | $11-$25k | 0 | 32,563.297 | 22,906.7031 | null | 14.75 | white | 24.296875 | 57 | 0.685913 | 0.592896 | 1 | 0 | 0 | yes | 0.5 | 0.3 | no dnr | 26 | 63 | 25.199219 | 126 | 42 | 38.29688 | 194.28125 | 2.599609 | 0.899902 | 1.099854 | 145 | 7.549805 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,886 | 80.93097 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 21 | $11-$25k | 0 | 57,927.031 | 39,838.1875 | null | 30 | white | 42.296875 | 62 | 0.194977 | 0.103989 | 1 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 16 | 134 | 1 | 126 | 36 | 36 | 160 | 2.399902 | 1.899902 | 3.5 | 142 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,887 | 50.95999 | 0 | female | 0 | 11 | 1,595 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 9 | 20,149.438 | 13,549.0859 | null | 22 | white | 19.597656 | 27 | 0.87793 | 0.835938 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 11 | 59 | 10.199219 | 120 | 6 | 38.09375 | 347.5625 | 2.599609 | 0.199982 | 0.699951 | 143 | 7.449219 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
3,888 | 50.64999 | 1 | male | 0 | 5 | 388 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 7,671.547 | 4,854.7148 | null | 12 | white | 10.5 | 9 | 0.902954 | 0.776978 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 5 | 117 | 12.699219 | 50 | 20 | 36.39844 | null | 4.199219 | 0.599976 | 1.099854 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,889 | 37.396 | 0 | male | 0 | 9 | 1,593 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | null | 0 | 27,632.438 | 17,343.8125 | null | 28 | black | 19.5 | 27 | 0.915894 | 0.885986 | 1 | 1 | 0 | no | 0.3 | 0.28 | no dnr | 9 | 61 | 6.899414 | 126 | 10 | 38.39844 | 223.3125 | 2.799805 | 0.599976 | 1.099854 | 153 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,890 | 68.02496 | 1 | male | 0 | 16 | 619 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 15 | >$50k | 0 | 27,549.688 | 18,694.5938 | null | 19.666656 | white | 26.597656 | 42 | 0.754883 | 0.67688 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 16 | 110 | 18.898438 | 104 | 40 | 36.59375 | 146.40625 | null | null | 0.899902 | 139 | 7.369141 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,891 | 59.86899 | 0 | male | 0 | 73 | 1,593 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | >$50k | 0 | 212,689.5 | 137,019 | null | 34.5 | white | 29.597656 | 42 | 0.736938 | 0.654907 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 73 | 117 | 14.898438 | 116 | 27 | 39.09375 | 216.65625 | 2.799805 | 6.399414 | 1.299805 | 131 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,892 | 74.59796 | 0 | male | 0 | 6 | 1,593 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 26 | 3,740.498 | 3,070.2441 | null | 14 | black | 27.5 | 31 | 0.611938 | 0.42395 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 101 | 8 | 100 | 24 | 35.5 | 356 | null | 6.799805 | 1.699951 | 146 | 7.459961 | null | null | null | null | null | null | 3.637207 |
3,893 | 69.00494 | 1 | female | 0 | 9 | 1,133 | CHF | COPD/CHF/Cirrhosis | 4 | 5 | $11-$25k | 0 | 20,171.688 | 12,962.7656 | null | 22.5 | white | 23.398438 | 47 | 0.807983 | 0.688965 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 9 | 124 | 6.699219 | 176 | 8 | 36.19531 | 233.3125 | null | null | 1.399902 | 137 | 7.389648 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,894 | 70.89398 | 1 | female | 1 | 6 | 6 | Coma | Coma | 3 | 11 | $25-$50k | 100 | 20,252.891 | 14,738.0078 | null | 32 | white | 22.199219 | 36 | 0.198975 | 0.138977 | 1 | 1 | 0 | no | null | null | dnr after sadm | 5 | 119 | 11.898438 | 100 | 8 | 36.79688 | 386.625 | null | null | 9.898438 | 133 | 7.399414 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,895 | 64.91998 | 1 | male | 0 | 32 | 156 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 44 | 107,884.5 | 66,731.6875 | null | 34.5 | white | 34.695313 | 75 | 0.109985 | 0.046997 | 14 | 0 | 0 | yes | null | null | no dnr | 32 | 55 | 49.398438 | 210 | 5 | 39.29688 | 253.3125 | 3 | null | 2 | 131 | 7.319336 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,896 | 67.88495 | 1 | female | 0 | 9 | 16 | Colon Cancer | Cancer | 2 | 14 | $25-$50k | 0 | 7,538.297 | 5,511.1602 | null | 12 | white | 24.296875 | 34 | 0.685913 | 0.392944 | 1 | 0 | 0 | metastatic | 0.3 | 0 | dnr after sadm | 1 | 77 | 4.299805 | 98 | 20 | 37.19531 | null | null | 19.097656 | 1.099854 | 135 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,897 | 52.99899 | 1 | male | 1 | 17 | 17 | Colon Cancer | Cancer | 1 | 10 | >$50k | 0 | 24,066.344 | 15,673.8203 | null | 12.333328 | black | 21.699219 | 36 | 0.771973 | 0.526978 | 1 | 0 | 0 | metastatic | null | null | no dnr | 17 | 126 | 4.599609 | 64 | 28 | 38.09375 | null | null | 13 | 1.099854 | 139 | null | null | null | null | 3 | null | <2 mo. follow-up | 2.511099 |
3,898 | 64.909 | 1 | male | 0 | 7 | 22 | Colon Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 3,950.5 | 2,913.9922 | null | 6.5 | white | 16.199219 | 26 | 0.827881 | 0.625977 | 1 | 1 | 0 | metastatic | 0.5 | 0.2 | no dnr | 7 | 67 | 5.399414 | 52 | 16 | 37.69531 | null | null | 0.199982 | 1.399902 | 135 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,899 | 30.795 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 55 | 59,516.188 | 36,226.1875 | null | 42 | white | 26.699219 | 33 | 0.720947 | 0.634888 | 2 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 13 | 55 | 13.398438 | 116 | 11 | 38.69531 | 148 | 2.5 | 0.5 | 0.899902 | 140 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.783691 |
3,900 | 38.133 | 0 | female | 0 | 91 | 1,587 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 44 | 202,750.625 | 130,006.375 | null | 24.5 | white | 29 | 50 | 0.599976 | 0.492981 | 22 | 0 | 0 | no | 0.15 | 0.1 | no dnr | 91 | 113 | 27.796875 | 140 | 33 | 38.59375 | 368 | 2.5 | 4.899414 | 1.699951 | 148 | 7.469727 | null | null | null | null | 2 | SIP>=30 | 2 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.